跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“ENZEEVU”
全部
10
临床试验
0
药物
0
机构
0
资讯
10
7个月前
Sandoz Canada Launches First Ophthalmology Biosimilar Enzeevu for Retinal Diseases
2年前
FDA Approves Pavblu, Fifth Biosimilar to Eylea, for Retinal Conditions
去年
Sandoz Resolves Patent Dispute with Regeneron, Clearing Path for Eylea Biosimilar Launch by 2026
去年
Sandoz Secures Patent Settlement with Regeneron, Clears Path for Aflibercept Biosimilar Launch by End of 2026
11个月前
Sandoz and Formycon Secure Aflibercept Biosimilar Settlement Agreements with Regeneron
去年
Sandoz's Aflibercept Biosimilar Afqlir Gains European Commission Approval
去年
Sandoz Reports 9% Growth in 2024, Driven by Strong Biosimilar Performance
去年
Australian Court Denies Preliminary Injunction Against Sandoz Aflibercept Biosimilar Launch
去年
Real-World Study Confirms Safety and Efficacy of Aflibercept Biosimilar Pavblu in 6,313 Patients
11年前
FDA Approves Two New Ustekinumab Biosimilars, Bringing Total US Biosimilar Count to 65